Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Vials 50ml total
Jiang Y, Chen M, Nie H, Yuan Y
Research Dosages and Protocols * Note: The listed dosages are based on reference research models and should be adapted to the specific requirements of your laboratory protocol
An initial injury often cascades into compensatory patterns that stress surrounding structures
Start with a low dose and increase gradually
Interestingly, in a recent study using resistant colon cancer stem-like cells and mouse models, combination therapy of regorafenib with two antagonists of IGF-1-R, namely aspirin and the selective dual insulin receptor and IGF-1R kinase inhibitor linsitinib (OSI-906), abrogated tumor resistance to regorafenib and restored the drugs ability to induce apoptosis in colon cancer stem-like cells and disease activity index (51)
